119 related articles for article (PubMed ID: 36867154)
1. Clinical Diagnostic Values of Transfer RNA-Derived Fragment tRF-41-YDLBRY73W0K5KKOVD and its Effects on the Growth of Gastric Cancer Cells.
Wang Y; Li Z; Weng Q; Zheng Y; Lin Y; Guo J; Ye G
DNA Cell Biol; 2023 Mar; 42(3):176-187. PubMed ID: 36867154
[TBL] [Abstract][Full Text] [Related]
2. Global profile of tRNA-derived small RNAs in gastric cancer patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor.
Shen Y; Yu X; Ruan Y; Li Z; Xie Y; Yan Z; Guo J
Int J Med Sci; 2021; 18(7):1570-1579. PubMed ID: 33746573
[TBL] [Abstract][Full Text] [Related]
3. A 3'-tRNA-derived fragment enhances cell proliferation, migration and invasion in gastric cancer by targeting FBXO47.
Zhang F; Shi J; Wu Z; Gao P; Zhang W; Qu B; Wang X; Song Y; Wang Z
Arch Biochem Biophys; 2020 Sep; 690():108467. PubMed ID: 32592804
[TBL] [Abstract][Full Text] [Related]
4. Transfer RNA-derived fragment tRF-23-Q99P9P9NDD promotes progression of gastric cancer by targeting
Zhang Y; Gu X; Li Y; Li X; Huang Y; Ju S
J Zhejiang Univ Sci B; 2024 May; 25(5):438-450. PubMed ID: 38725342
[TBL] [Abstract][Full Text] [Related]
5. The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.
Zhu L; Li Z; Yu X; Ruan Y; Shen Y; Shao Y; Zhang X; Ye G; Guo J
Stem Cell Res Ther; 2021 Jul; 12(1):418. PubMed ID: 34294122
[TBL] [Abstract][Full Text] [Related]
6. Clinical diagnostic values of transfer RNA-derived fragment tRF-19-3L7L73JD and its effects on the growth of gastric cancer cells.
Shen Y; Xie Y; Yu X; Zhang S; Wen Q; Ye G; Guo J
J Cancer; 2021; 12(11):3230-3238. PubMed ID: 33976732
[No Abstract] [Full Text] [Related]
7. Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric Cancer.
Li Y; Zhang Y; Li X; Li X; Gu X; Ju S
Int J Med Sci; 2023; 20(9):1189-1201. PubMed ID: 37575270
[No Abstract] [Full Text] [Related]
8. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
9. microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1.
Ma X; Feng J; Lu M; Tang W; Han J; Luo X; Zhao Q; Yang L
J Cell Biochem; 2020 Feb; 121(2):1911-1922. PubMed ID: 31746031
[TBL] [Abstract][Full Text] [Related]
10. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer.
Zhang Y; Gu X; Qin X; Huang Y; Ju S
Mol Med; 2022 Jun; 28(1):63. PubMed ID: 35690737
[TBL] [Abstract][Full Text] [Related]
12. tRFs as Potential Exosome tRNA-Derived Fragment Biomarkers for Gastric Carcinoma.
Lin C; Zheng L; Huang R; Yang G; Chen J; Li H
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538051
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
[TBL] [Abstract][Full Text] [Related]
14. MiR-200a-3p promotes gastric cancer progression by targeting DLC-1.
Li Z; Wang Y; Liu S; Li W; Wang Z; Jia Z; Zhu Z; Bao Y
J Mol Histol; 2022 Feb; 53(1):39-49. PubMed ID: 34751841
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer.
Li X; Zhang Y; Li Y; Gu X; Ju S
Mol Carcinog; 2023 Oct; 62(10):1504-1517. PubMed ID: 37314123
[TBL] [Abstract][Full Text] [Related]
16. Transfer RNA-derived fragments as novel biomarkers of the onset and progression of gastric cancer.
Xie Y; Zhang S; Yu X; Ye G; Guo J
Exp Biol Med (Maywood); 2023 Jul; 248(13):1095-1102. PubMed ID: 37387464
[TBL] [Abstract][Full Text] [Related]
17. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
18. A novel 3'tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer.
Cui H; Li H; Wu H; Du F; Xie X; Zeng S; Zhang Z; Dong K; Shang L; Jing C; Li L
Cell Death Dis; 2022 May; 13(5):471. PubMed ID: 35585048
[TBL] [Abstract][Full Text] [Related]
19. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.
Zhong X; Wen X; Chen L; Gu N; Yu X; Sui K
J Gene Med; 2021 May; 23(5):e3330. PubMed ID: 33682985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
